首页> International journal of gynecological cancer : official journal of the International Gynecological Cancer Society> CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study.

CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study.

导出 OA

翻译打印收藏纠错

第一作者： Jyoti,Mayadev

第一单位： GYN Cancers, Rebecca and John Moores Cancer Center, La Jolla, California, USA.

作者： Jyoti,Mayadev ^[1] ; Ana T,Nunes ^[2] ; Mary,Li ^[2] ; Michelle,Marcovitz ^[2] ; Mark C,Lanasa ^[2] ; Bradley J,Monk ^[3]

作者单位： GYN Cancers, Rebecca and John Moores Cancer Center, La Jolla, California, USA. ^[1] AstraZeneca R&D Gaithersburg, Gaithersburg, Maryland, USA. ^[2] Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Creighton University School of Medicine at St. Josephs Hospital and Medical Center, Phoenix, Arizona, USA bradley.monk@usoncology.com. ^[3]

关键词 intestine, large pain peritoneal neoplasms ureter uterus

医学主题词临床试验, Ⅲ期(主题)(Clinical Trials, Phase III as Topic);双盲法(Double-Blind Method);女(雌)性(Female);人类(Humans);多中心研究(主题)(Multicenter Studies as Topic);随机对照试验(主题)(Randomized Controlled Trials as Topic);宫颈肿瘤(Uterine Cervical Neoplasms)

DOI 10.1136/ijgc-2019-001135

PMID 32447296

发布时间 2025-04-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交